Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights. | Onco Targets Ther;16: 675-687, 2023. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Biblioteca Virtual en Salud

BVS - Literatura Cientifica y Técnica

Localizar descriptor de asunto Búsqueda Avanzada

Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights.

Chatterjee, Annesha; Azevedo-Martins, Jordana Maria; Stachler, Matthew D.

Chatterjee A; University of California San Francisco, Department of Pathology, San Francisco, CA, USA.
Azevedo-Martins JM; University of California San Francisco, Department of Pathology, San Francisco, CA, USA.
Stachler MD; University of California San Francisco, Department of Pathology, San Francisco, CA, USA.

Onco Targets Ther ; 16: 675-687, 2023.

Article en En | MEDLINE | ID: mdl-37583706

Palabras clave

gastric cancer; interleukin-33; therapeutic target

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article